Home/Filings/4/0001610618-22-000078
4//SEC Filing

Tari Leslie 4

Accession 0001610618-22-000078

CIK 0001610618other

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 6:48 PM ET

Size

6.0 KB

Accession

0001610618-22-000078

Insider Transaction Report

Form 4
Period: 2022-09-12
Tari Leslie
CHIEF SCIENTIFIC OFFICER
Transactions
  • Sale

    Common Stock

    2022-09-12$0.68/sh18,159$12,437193,741 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    13,298
Footnotes (2)
  • [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on September 10, 2022. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
  • [F2]Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2022.

Issuer

Cidara Therapeutics, Inc.

CIK 0001610618

Entity typeother

Related Parties

1
  • filerCIK 0001870270

Filing Metadata

Form type
4
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 6:48 PM ET
Size
6.0 KB